Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Inflation Reduction Act Research Series: Understanding Development and Trends in Utilization and Spending for Drugs Selected Under the Medicare Drug Price Negotiation Program

Publication Date

The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition. Negotiations with participating manufacturers for the first group of selected drugs begin in 2023, with negotiated maximum fair prices going into effect in 2026. We present information on the development of selected drugs and Medicare use and spending for these drugs from 2018 through 2022.

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Bisma Sayed, (202)240-3884, Content will be updated pending the outcome of the Section 508 review.

Related Products:

Product Type
Fact Sheet | Report
Older Adults | Black & African American People | American Indian & Alaska Native People (AI-AN) | Asian American & Pacific Islanders People (AAPI) | Hispanic, Latino, Latina, & Latinx People | Racial & Ethnic Groups | White People | Medicare Beneficiaries
Location- & Geography-Based Data
National Data | State Data
Medicare | Medicare Part D